Fig. 1From: Immunotherapy Bridge 2019 and Melanoma Bridge 2019: meeting abstractsKaplan–Meier survival curves according to the occurrence of late-irAEs (A) Time to Treatment Failure (B) Overall SurvivalBack to article page